Cargando…
Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic?
Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share commo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460384/ https://www.ncbi.nlm.nih.gov/pubmed/26126856 |
_version_ | 1782375380059947008 |
---|---|
author | Michalopoulos, George Vrakas, Spyridon Makris, Konstantinos Tzathas, Charalampos |
author_facet | Michalopoulos, George Vrakas, Spyridon Makris, Konstantinos Tzathas, Charalampos |
author_sort | Michalopoulos, George |
collection | PubMed |
description | Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share common serologic and epidemiologic characteristics making the differentiation between those two entities difficult. We present a case of a 35-year-old woman with CD who developed SLE after treatment with adalimumab and denosumab and persisting symptoms eight months after discontinuation of those agents. |
format | Online Article Text |
id | pubmed-4460384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hellenic Society of Gastroenterology |
record_format | MEDLINE/PubMed |
spelling | pubmed-44603842015-07-01 Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? Michalopoulos, George Vrakas, Spyridon Makris, Konstantinos Tzathas, Charalampos Ann Gastroenterol Case Report Coexistence of Crohn’s disease (CD) and idiopathic systemic lupus erythematosus (SLE) is very rare. On the other hand, drug-induced lupus erythematosus (DILE) due to anti-tumor necrosis factor (TNF) agents is a relatively more common entity. DILE due to anti-TNF agents and idiopathic SLE share common serologic and epidemiologic characteristics making the differentiation between those two entities difficult. We present a case of a 35-year-old woman with CD who developed SLE after treatment with adalimumab and denosumab and persisting symptoms eight months after discontinuation of those agents. Hellenic Society of Gastroenterology 2015 /pmc/articles/PMC4460384/ /pubmed/26126856 Text en Copyright: © Hellenic Society of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Michalopoulos, George Vrakas, Spyridon Makris, Konstantinos Tzathas, Charalampos Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? |
title | Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? |
title_full | Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? |
title_fullStr | Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? |
title_full_unstemmed | Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? |
title_short | Systemic lupus erythematosus in Crohn’s disease: drug-induced or idiopathic? |
title_sort | systemic lupus erythematosus in crohn’s disease: drug-induced or idiopathic? |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460384/ https://www.ncbi.nlm.nih.gov/pubmed/26126856 |
work_keys_str_mv | AT michalopoulosgeorge systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic AT vrakasspyridon systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic AT makriskonstantinos systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic AT tzathascharalampos systemiclupuserythematosusincrohnsdiseasedruginducedoridiopathic |